Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Hilliard. Study-provided care at no cost to qualified participants.
Access ovarian cancer specialists in Hilliard at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ovarian cancer treatment provided free
The goal of this clinical trial is to learn if the experimental antibody COM701 delays the progression of ovarian cancer in participants with Relapsed Platinum Sensitive Ovarian Cancer. It will also learn about the safety of COM701. The main questions the trial aims to answer are: * Does COM701, when used as a maintenance treatment, stop or slow the progression of ovarian cancer? * Does COM701 delay the time to needing a new anti-cancer treatment? * What side effects do participants have when
Sponsor: Compugen Ltd
Check if you qualify for this ovarian cancer clinical trial in Hilliard, OH
If you're searching for ovarian cancer treatment options in Hilliard, OH, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hilliard research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.